{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T10:53:39Z","timestamp":1773572019686,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["NET-MET-2022-74012"],"award-info":[{"award-number":["NET-MET-2022-74012"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["MET exoCancer-2021-74012"],"award-info":[{"award-number":["MET exoCancer-2021-74012"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canc\u00e9rop\u00f4le Nord-Ouest EMERGENCE 2022"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The MET exon 14 skipping mutation (named METex14Del) described in lung cancer leads to prolonged activation of signaling pathways and aberrant cell responses, but the link between HGF signaling and cell responses remains unclear. A putative lung cancer regulatory network of influential transcription factors was constructed from the transcriptomes of lung cancer cell lines. Transcriptomic data from METex14Del-expressing cells, stimulated or not by HGF, were mapped onto this lung cancer reference network and revealed activation of a major regulatory node composed mainly by the highly influential transcription factors ETS1, FOSL1 and SMAD3. HGF activation of METex14Del receptor induced the expression and phosphorylation of these three master regulators and the expression of their predicted target genes involved in migration and invasion. All these molecular and biological effects were inhibited by trametinib, a MEK inhibitor, which was potentiated by combination with capmatinib, a MET inhibitor. New mapping with transcriptomic data from trametinib-treated METex14Del cells validated the key role of the RAS-ERK pathway signaling in the activation of ETS1, FOSL1 and SMAD3 regulators and the induction of their target genes in HGF-activated METex14Del receptor. Thus, we report an original and powerful strategy to uncover key regulators, including transcription factors that have not been widely described in METex14Del signaling, such as SMAD3. These factors are activated by specific signaling pathways and could provide a novel therapeutic strategy involving a combination of receptor and signaling inhibitors.<\/jats:p>","DOI":"10.1038\/s41419-025-08086-x","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:05:54Z","timestamp":1762178754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive map of the regulatory network triggered by MET exon 14 skipping reveals important involvement of the RAS-ERK signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6697-6266","authenticated-orcid":false,"given":"Marie-Jos\u00e9","family":"Truong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pascal","family":"Meneboo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sh\u00e9h\u00e9razade","family":"Sebda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Figeac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-2904","authenticated-orcid":false,"given":"Mohamed","family":"Elati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-7242","authenticated-orcid":false,"given":"David","family":"Tulasne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"8086_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell Signaling by Receptor Tyrosine Kinases. Cell. 2010;141:1117\u201334.","journal-title":"Cell"},{"key":"8086_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2023.194988","volume":"1866","author":"J Chakraborty","year":"2023","unstructured":"Chakraborty J, Chakraborty S, Chakraborty S, Narayan MN. Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders. Biochim Biophys Acta Gene Regul Mech. 2023;1866:194988.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"8086_CR3","doi-asserted-by":"crossref","unstructured":"Weinstein IB. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science. 2002;297:63\u20134.","DOI":"10.1126\/science.1073096"},{"key":"8086_CR4","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1038\/s41388-021-01841-2","volume":"40","author":"P Saraon","year":"2021","unstructured":"Saraon P, Pathmanathan S, Snider J, Lyakisheva A, Wong V, Stagljar I. Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches. Oncogene. 2021;40:4079\u201393.","journal-title":"Oncogene"},{"key":"8086_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01168-8","volume":"7","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li S, Wang Y, Zhao Y, Li Q. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. Sig Transd Target Ther. 2022;7:1\u201336.","journal-title":"Sig Transd Target Ther"},{"key":"8086_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"The Cancer Genome Atlas Research Network.","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543\u201350.","journal-title":"Nature"},{"key":"8086_CR7","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.jtho.2018.08.2023","volume":"13","author":"C Descarpentries","year":"2018","unstructured":"Descarpentries C, Lepretre F, Escande F, Kherrouche Z, Figeac M, Sebda S, et al. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients. J Thorac Oncol. 2018;13:1873\u201383.","journal-title":"J Thorac Oncol"},{"key":"8086_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1158\/2159-8290.CD-15-0285","volume":"5","author":"GM Frampton","year":"2015","unstructured":"Frampton GM, Ali SM, Rosenzweig M, Chmielecki J, Lu X, Bauer TM, et al. Activation of MET via Diverse Exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer Discov. 2015;5:850\u20139.","journal-title":"Cancer Discov"},{"key":"8086_CR9","doi-asserted-by":"publisher","first-page":"djw262.","DOI":"10.1093\/jnci\/djw262","volume":"109","author":"AB Cortot","year":"2017","unstructured":"Cortot AB, Kherrouche Z, Descarpentries C, Wislez M, Baldacci S, Furlan A. et al. Exon 14 deleted MET receptor as a new biomarker and target in cancers. J Natl Cancer Inst. 2017;109:djw262.","journal-title":"J Natl Cancer Inst"},{"key":"8086_CR10","doi-asserted-by":"crossref","unstructured":"Fernandes M, Paget S, Kherrouche Z, Truong MJ, Vinchent A, Meneboo JP, et al. Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site. FEBS Lett. 2023;597:2301\u201315.","DOI":"10.1002\/1873-3468.14702"},{"key":"8086_CR11","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/1878-0261.13397","volume":"17","author":"M Fernandes","year":"2023","unstructured":"Fernandes M, Hoggard B, Jamme P, Paget S, Truong MJ, Gr\u00e9goire V, et al. ME Texon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependentoncogenic driver in vitro and in humanised HGF knock-in mice. Mol Oncol. 2023;17:2257\u201374.","journal-title":"Mol Oncol"},{"key":"8086_CR12","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/cancers14061378","volume":"14","author":"D Lu","year":"2022","unstructured":"Lu D, Nagelberg A, Chow JL, Chen YT, Michalchuk Q, Somwar R, et al. MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis. Cancers. 2022;14:1378.","journal-title":"Cancers"},{"key":"8086_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41416-023-02495-5","volume":"130","author":"Q Liang","year":"2024","unstructured":"Liang Q, Hu Y, Yuan Q, Yu M, Wang H, Zhao B. MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling. Br J Cancer. 2024;130:380\u201393.","journal-title":"Br J Cancer"},{"key":"8086_CR14","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/S0021-9258(17)42099-0","volume":"269","author":"L Gandino","year":"1994","unstructured":"Gandino L, Longati P, Medico E, Prat M, Comoglio PM. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J Biol Chem. 1994;269:1815\u201320.","journal-title":"J Biol Chem"},{"key":"8086_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cyto.2013.04.006","volume":"62","author":"M Nakayama","year":"2013","unstructured":"Nakayama M, Sakai K, Yamashita A, Nakamura T, Suzuki Y, Matsumoto K. Met\/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes. Cytokine. 2013;62:446\u201352.","journal-title":"Cytokine"},{"key":"8086_CR16","doi-asserted-by":"publisher","first-page":"29565","DOI":"10.1074\/jbc.M403954200","volume":"279","author":"P Peschard","year":"2004","unstructured":"Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl\/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem. 2004;279:29565\u201371.","journal-title":"J Biol Chem"},{"key":"8086_CR17","doi-asserted-by":"publisher","first-page":"9632","DOI":"10.1128\/MCB.25.21.9632-9645.2005","volume":"25","author":"JV Abella","year":"2005","unstructured":"Abella JV, Peschard P, Naujokas MA, Lin T, Saucier C, Urbe S, et al. Met\/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol Cell Biol. 2005;25:9632\u201345.","journal-title":"Mol Cell Biol"},{"key":"8086_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1097-2765(01)00378-1","volume":"8","author":"P Peschard","year":"2001","unstructured":"Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Molecular Cell. 2001;8:995\u20131004.","journal-title":"Molecular Cell"},{"key":"8086_CR19","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1128\/MCB.24.23.10328-10339.2004","volume":"24","author":"D Tulasne","year":"2004","unstructured":"Tulasne D, Deheuninck J, Lourenco FC, Lamballe F, Ji Z, Leroy C, et al. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol. 2004;24:10328\u201339.","journal-title":"Mol Cell Biol"},{"key":"8086_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.cdd.4402080","volume":"14","author":"B Foveau","year":"2007","unstructured":"Foveau B, Leroy C, Ancot F, Deheuninck J, Ji Z, Fafeur V, et al. Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ. 2007;14:752\u201364.","journal-title":"Cell Death Differ"},{"key":"8086_CR21","doi-asserted-by":"crossref","unstructured":"Duplaquet L, Leroy C, Vinchent A, Paget S, Lefebvre J, Vanden Abeele F. Control of cell death\/survival balance by the MET dependence receptor. eLife. 2020;9:e50041.","DOI":"10.7554\/eLife.50041"},{"key":"8086_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.377","volume":"4","author":"J Lefebvre","year":"2013","unstructured":"Lefebvre J, Muharram G, Leroy C, Kherrouche Z, Montagne R, Ichim G, et al. Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity. Cell Death Dis. 2013;4:e871.","journal-title":"Cell Death Dis"},{"key":"8086_CR23","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1093\/bioinformatics\/btv305","volume":"31","author":"R Nicolle","year":"2015","unstructured":"Nicolle R, Radvanyi F, Elati M. CoRegNet: reconstruction and integrated analysis of co-regulatory networks. Bioinformatics. 2015;31:3066\u20138.","journal-title":"Bioinformatics"},{"key":"8086_CR24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"8086_CR25","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","volume":"20","author":"TF Galatro","year":"2017","unstructured":"Galatro TF, Holtman IR, Lerario AM, Vainchtein ID, Brouwer N, Sola PR, et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat Neurosci. 2017;20:1162\u201371.","journal-title":"Nat Neurosci"},{"key":"8086_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05044-2","volume":"7","author":"Y Lou","year":"2017","unstructured":"Lou Y, Tian GY, Song Y, Liu YL, Chen YD, Shi JP, et al. Characterization of transcriptional modules related to fibrosing-NAFLD progression. Sci Rep. 2017;7:4748.","journal-title":"Sci Rep"},{"key":"8086_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73147-4","volume":"10","author":"N Zerrouk","year":"2020","unstructured":"Zerrouk N, Miagoux Q, Dispot A, Elati M, Niarakis A. Identification of putative master regulators in rheumatoid arthritis synovial fibroblasts using gene expression data and network inference. Sci Rep. 2020;10:16236.","journal-title":"Sci Rep"},{"key":"8086_CR28","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"8086_CR29","doi-asserted-by":"publisher","first-page":"D408","DOI":"10.1093\/nar\/gkw985","volume":"45","author":"G Alanis-Lobato","year":"2017","unstructured":"Alanis-Lobato G, Andrade-Navarro MA, Schaefer MH. HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks. Nucleic Acids Res. 2017;45:D408\u201314.","journal-title":"Nucleic Acids Res"},{"key":"8086_CR30","doi-asserted-by":"publisher","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","volume":"46","author":"CA Davis","year":"2018","unstructured":"Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, et al. The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018;46:D794\u2013801.","journal-title":"Nucleic Acids Res"},{"key":"8086_CR31","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma\u2019ayan A. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010;26:2438\u201344.","journal-title":"Bioinformatics"},{"key":"8086_CR32","doi-asserted-by":"crossref","unstructured":"Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, et al. Hepatocyte growth factor\/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene. 2002;21:2309\u201319.","DOI":"10.1038\/sj.onc.1205297"},{"key":"8086_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/MCB.16.2.538","volume":"16","author":"BS Yang","year":"1996","unstructured":"Yang BS, Hauser CA, Henkel G, Colman MS, Beveren CV, Stacey KJ, et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol. 1996;16:538.","journal-title":"Mol Cell Biol"},{"key":"8086_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner JE, Hnisz D, Young RA. Transcriptional Addiction in Cancer. Cell. 2017;168:629\u201343.","journal-title":"Cell"},{"key":"8086_CR35","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","volume":"152","author":"TI Lee","year":"2013","unstructured":"Lee TI, Young RA. Transcriptional regulation and its misregulation in disease. Cell. 2013;152:1237\u201351.","journal-title":"Cell"},{"key":"8086_CR36","first-page":"346","volume":"14","author":"J Linde","year":"2015","unstructured":"Linde J, Schulze S, Henkel SG, Guthke R. Data- and knowledge-based modeling of gene regulatory networks: an update. EXCLI J. 2015;14:346\u201378.","journal-title":"EXCLI J"},{"key":"8086_CR37","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/bioinformatics\/btm352","volume":"23","author":"M Elati","year":"2007","unstructured":"Elati M, Neuvial P, Bolotin-Fukuhara M, Barillot E, Radvanyi F, Rouveirol C. LICORN: learning cooperative regulation networks from gene expression data. Bioinformatics. 2007;23:2407\u201314.","journal-title":"Bioinformatics"},{"key":"8086_CR38","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1158\/0008-5472.CAN-21-1327","volume":"82","author":"F Wang","year":"2022","unstructured":"Wang F, Liu Y, Qiu W, Shum E, Feng M, Zhao D, et al. Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination. Cancer Res. 2022;82:1365\u201379.","journal-title":"Cancer Res"},{"key":"8086_CR39","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/1878-0261.13806","volume":"19","author":"C Gu\u00e9rin","year":"2025","unstructured":"Gu\u00e9rin C, Vinchent A, Fernandes M, Damour I, Laratte A, Tellier R, et al. MET variants with activating N-lobe mutations identified inhereditary papillary renal cell carcinomas still require ligand stimulation. Mol Oncol. 2025;19:2366\u201387.","journal-title":"Mol Oncol"},{"key":"8086_CR40","doi-asserted-by":"publisher","first-page":"e202201409","DOI":"10.26508\/lsa.202201409","volume":"5","author":"M Cerqua","year":"2022","unstructured":"Cerqua M, Botti O, Arigoni M, Gioelli N, Serini G, Calogero R, et al. MET\u220614 promotes a ligand-dependent, AKT-driven invasive growth. Life Sci Alliance. 2022;5:e202201409.","journal-title":"Life Sci Alliance"},{"key":"8086_CR41","doi-asserted-by":"publisher","first-page":"46661","DOI":"10.1074\/jbc.M105816200","volume":"276","author":"RK Lindemann","year":"2001","unstructured":"Lindemann RK, Ballschmieter P, Nordheim A, Dittmer J. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad\/Ets synergism. J Biol Chem. 2001;276:46661\u201370.","journal-title":"J Biol Chem"},{"key":"8086_CR42","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/sj.onc.1207064","volume":"23","author":"M Jinnin","year":"2004","unstructured":"Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene. 2004;23:1656\u201367.","journal-title":"Oncogene"},{"key":"8086_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/ar1890","volume":"8","author":"JP Van Beek","year":"2006","unstructured":"Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A. The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther. 2006;8:R36.","journal-title":"Arthritis Res Ther"},{"key":"8086_CR44","first-page":"1","volume":"10","author":"D Liu","year":"2019","unstructured":"Liu D, Wang K, Li K, Xu R, Chang X, Zhu Y, et al. Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-\u03b21 signaling-mediated hepatocyte apoptosis. Cell Death Dis. 2019;10:1\u201314.","journal-title":"Cell Death Dis"},{"key":"8086_CR45","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1038\/onc.2012.370","volume":"32","author":"A Sundqvist","year":"2013","unstructured":"Sundqvist A, Zieba A, Vasilaki E, Herrera Hidalgo C, S\u00f6derberg O, Koinuma D, et al. Specific interactions between Smad proteins and AP-1 components determine TGF\u03b2-induced breast cancer cell invasion. Oncogene. 2013;32:3606\u201315.","journal-title":"Oncogene"},{"key":"8086_CR46","doi-asserted-by":"publisher","first-page":"29469","DOI":"10.1074\/jbc.M110.142018","volume":"285","author":"K Kaddatz","year":"2010","unstructured":"Kaddatz K, Adhikary T, Finkernagel F, Meissner W, M\u00fcller-Br\u00fcsselbach S, M\u00fcller R. Transcriptional profiling identifies functional interactions of TGF \u03b2 and PPAR \u03b2\/\u03b4 signaling: synergistic induction of ANGPTL4 transcription. J Biol Chem. 2010;285:29469\u201379.","journal-title":"J Biol Chem"},{"key":"8086_CR47","first-page":"877","volume":"13","author":"B Rabault","year":"1996","unstructured":"Rabault B, Roussel MF, Quang CT, Ghysdael J. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene. 1996;13:877\u201381.","journal-title":"Oncogene"},{"key":"8086_CR48","first-page":"2537","volume":"9","author":"MC Gruda","year":"1994","unstructured":"Gruda MC, Kovary K, Metz R, Bravo R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene. 1994;9:2537\u201347.","journal-title":"Oncogene"},{"key":"8086_CR49","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1128\/MCB.01776-06","volume":"27","author":"J Basbous","year":"2007","unstructured":"Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1\/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol. 2007;27:3936\u201350.","journal-title":"Mol Cell Biol"},{"key":"8086_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1165\/rcmb.2007-0206OC","volume":"38","author":"ME Ramos-Nino","year":"2008","unstructured":"Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Pass H, Carbone M, Testa JR, et al. HGF mediates cell proliferation of human mesothelioma cells through a PI3K\/MEK5\/Fra-1 pathway. Am J Respir Cell Mol Biol. 2008;38:209\u201317.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"8086_CR51","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1038\/sj.onc.1207981","volume":"23","author":"S Mori","year":"2004","unstructured":"Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, et al. TGF-\u03b2 and HGF transmit the signals through JNK-dependent Smad2\/3 phosphorylation at the linker regions. Oncogene. 2004;23:7416\u201329.","journal-title":"Oncogene"},{"key":"8086_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1385\/IJGC:31:1-3:61","volume":"31","author":"V Ellenrieder","year":"2002","unstructured":"Ellenrieder V, Buck A, Gress TM. TGF\u03b2-regulated transcriptional mechanisms in cancer. Int J Gastrointest Canc. 2002;31:61\u20139.","journal-title":"Int J Gastrointest Canc"},{"key":"8086_CR53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","volume":"23","author":"JM Franklin","year":"2023","unstructured":"Franklin JM, Wu Z, Guan KL. Insights into recent findings and clinical application of YAP and TAZ in cancer. Nat Rev Cancer. 2023;23:512\u201325.","journal-title":"Nat Rev Cancer"},{"key":"8086_CR54","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211754","volume":"42","author":"P Debnath","year":"2022","unstructured":"Debnath P, Huirem RS, Dutta P, Palchaudhuri S. Epithelial-mesenchymal transition and its transcription factors. Biosci Rep. 2022;42:BSR20211754.","journal-title":"Biosci Rep"},{"key":"8086_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2005.09.008","volume":"17","author":"AB Roberts","year":"2006","unstructured":"Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, et al. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 2006;17:19\u201327.","journal-title":"Cytokine Growth Factor Rev"},{"key":"8086_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcancer.2015.09.010","volume":"35","author":"J Dittmer","year":"2015","unstructured":"Dittmer J. The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol. 2015;35:20\u201338.","journal-title":"Semin Cancer Biol"},{"key":"8086_CR57","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/ijms23031521","volume":"23","author":"VV Sobolev","year":"2022","unstructured":"Sobolev VV, Khashukoeva AZ, Evina OE, Geppe NA, Chebysheva SN, Korsunskaya IM, et al. Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis. Int J Mol Sci. 2022;23:1521.","journal-title":"Int J Mol Sci"},{"key":"8086_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1320887","volume":"14","author":"Q Ma","year":"2024","unstructured":"Ma Q, Ye S, Liu H, Zhao Y, Mao Y, Zhang W. HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition. Front Oncol. 2024;14:1320887.","journal-title":"Front Oncol"},{"key":"8086_CR59","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jtho.2020.01.027","volume":"15","author":"P Jamme","year":"2020","unstructured":"Jamme P, Fernandes M, Copin MC, Descarpentries C, Escande F, Morabito A, et al. Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations. J Thorac Oncol. 2020;15:741\u201351.","journal-title":"J Thorac Oncol"},{"key":"8086_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"8086_CR61","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, et al. The Human Transcription Factors. Cell. 2018;172:650\u201365.","journal-title":"Cell"},{"key":"8086_CR62","doi-asserted-by":"publisher","first-page":"D145","DOI":"10.1093\/nar\/gkw1007","volume":"45","author":"S Schmeier","year":"2017","unstructured":"Schmeier S, Alam T, Essack M, Bajic VB. TcoF-DB v2: update of the database of human and mouse transcription co-factors and transcription factor interactions. Nucleic Acids Res. 2017;45:D145\u201350.","journal-title":"Nucleic Acids Res"},{"key":"8086_CR63","unstructured":"Paul Shannon MR. MotifDb [Internet]. Bioconductor; 2017 [cited 2024 Oct 21]. Available from: https:\/\/bioconductor.org\/packages\/MotifDb."},{"key":"8086_CR64","unstructured":"Robert Stojnic DD. PWMEnrich [Internet]. Bioconductor; 2017 [cited 2024 Oct 21]. Available from: https:\/\/bioconductor.org\/packages\/PWMEnrich."},{"key":"8086_CR65","doi-asserted-by":"crossref","unstructured":"Kou Y, Chen EY, Clark NR, Duan Q, Tan CM, Ma\u2019ayan A. ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome. In: Cuzzocrea A, Kittl C, Simos DE, Weippl E, Xu L, editors. Availability, Reliability, and Security in Information Systems and HCI. Berlin, Heidelberg: Springer; 2013. p. 416\u201330.","DOI":"10.1007\/978-3-642-40511-2_30"},{"key":"8086_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-455","volume":"12","author":"A Mora","year":"2011","unstructured":"Mora A, Donaldson IM. iRefR: an R package to manipulate the iRefIndex consolidated protein interaction database. BMC Bioinforma. 2011;12:455.","journal-title":"BMC Bioinforma"},{"key":"8086_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2481-y","volume":"19","author":"W Dhifli","year":"2019","unstructured":"Dhifli W, Puig J, Dispot A, Elati M. Latent network-based representations for large-scale gene expression data analysis. BMC Bioinforma. 2019;19:466.","journal-title":"BMC Bioinforma"},{"key":"8086_CR68","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"8086_CR69","first-page":"417","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database Hallmark Gene Set Collection. Cels. 2015;1:417\u201325.","journal-title":"Cels"},{"key":"8086_CR70","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.","journal-title":"Innovation"},{"key":"8086_CR71","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08086-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:07:53Z","timestamp":1762182473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8086"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08086-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5346581\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"783"}}